Injection Laboratory Animal Medicine Thymopentin Acetate C10H14OSn

Thymopentin is a five amino acid fragment of thymopoietin that exhibits immunostimulatory and anticancer activities.

Thymopentin decreases iNOS activity in the treatment of Sezary Syndrome, a severe form of lymphoma.

In leukemia cells, thymopentin inhibits proliferation and colony formation and induces differentiation.

In macrophages, thymopentin increases pro-inflammatory cytokine secretion, activation of NF-κB, production of HSP72, and signaling by JNK.

Thymopentin shows clinical benefit when used as an adjuvant, improving the response rate in subjects administered hepatitis B vaccines.

It can be used in patients with malignant tumors after chemoradiotherapy, immune function impairment; treatment of hepatitis B; major surgery and serious infection; autoimmune diseases such as rheumatoid arthritis, lupus erythematosus; type II diabetes, climacteric syndrome Older and younger people with lower immune function.

(1) For patients with chronic hepatitis B over 18 years of age.

(2) various primary or secondary T cell deficiency diseases (such as children with congenital immunodeficiency disease).

(3) Certain autoimmune diseases (such as rheumatoid arthritis, systemic lupus erythematosus).

(4) Various diseases with low cellular immune function.

.